GPT Healthcare Ltd - 544131 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find enclosed herewith intimation for investor meet on June 3, 2024.29-05-2024
29-05-2024
GPT Healthcare Ltd - 544131 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find enclosed herewith the transcript of the earnings call held on May 22, 2024 for Q42024.27-05-2024
GPT Healthcare Ltd - 544131 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the Copies of News Paper Publication for the Audited Financial Results for Q4 and year ended March 31, 2024.23-05-2024
GPT Healthcare Ltd - 544131 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed herewith the Annual Secretarial Compliance Report issued by Practicing Company Secretary for the year ended March 31, 2024.23-05-2024
GPT Healthcare Ltd - 544131 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Please find enclosed herewith the link of the Audio recording of the Earnings Call held today i.e. Wednesday, May 22, 202422-05-2024
GPT Healthcare Ltd - 544131 - Announcement under Regulation 30 (LODR)-Change in Directorate
Enclosed please find the details of Re-appointment of Directors subject to the approval of the shareholders.21-05-2024
Q4FY24 Quarterly & FY24 Annual Result Announced for GPT Healthcare Ltd.
Healthcare Facilities company GPT Healthcare announced Q4FY24 & FY24 results: Q4FY24 Financial Highlights: Total Income stood at Rs 101 crore, higher by 3.3% YoY EBITDA stood at Rs 25 crore, with EBITDA margin of 24.6% PAT stood at Rs.13 crore, higher by 23.1% YoY FY24 Financial Highlights: Total Income stood at Rs 406 crore, higher by 10.6% YoY EBITDA stood at Rs 93 crore, with EBITDA margin of 23.0%, an increase of 16.3% YoY PAT stood at Rs 48 crore, higher by 22.4% YoY The Total Dividend declared for FY24 of Rs 3.5 per share, including final dividend of Rs 1.50 per share Commenting on the performance, GPT Healthcare Chairman, Dwarika Prasad Tantia, said, “We have always focused on strong operational and financial parameters, along with superior clinical outcomes and this is reflective in our results for the quarter as well as for the year ended March 31, 2024. The existing four hospitals in Salt Lake, Agartala, Dum Dum and Howrah, continue to perform well and are improving on all financial and operational metrics with increasing occupancy. The ARPOB for FY24 was Rs 32,947 which is in line with our policy of serving the aspiring population of the society with higher disposable income in the middle to high income segment. The payer mix continues to be mostly cash and insurance leading to one of the highest Cashflow from Operations to EBITDA for the industry as well as both ROE and ROCE being in excess of 25% each and we expect to maintain the same, giving the shareholders superior return. With a focused geographical presence in eastern India, an under-penetrated region in terms of quality healthcare, GPT Healthcare stands as a beacon of excellence. Despite our rapid growth, our dedication to patient care, professional integrity, and medical excellence remains unwavering, only strengthening with time. Our long-term vision at GPT Healthcare is deeply rooted in our commitment to bringing advanced medical care to under-served markets in cities across eastern India. We aim to establish a chain of 150 to 200-bedded hospitals in these burgeoning markets, thereby fulfilling the pressing need for modern healthcare facilities in these areas. Our upcoming hospital in Raipur is on track and is expected to be commissioned in Q4 FY 25 and the radiation oncology to be commissioned in Agartala hospital in CY24. By strategically expanding our presence and offering advanced medical services in these underserved regions, we not only aim to meet the evolving healthcare needs of the populace but also contribute to the overall development and well-being of these communities. Our vision is to become a trusted healthcare partner, providing accessible, highquality medical care to every individual, regardless of their geographic location or socio-economic background.” Result PDF21-05-2024
GPT Healthcare Ltd - 544131 - Statement Of Deviation For The Quarter Ended March 31, 2024.
Please find the Statement of Deviation for the quarter ended March 31, 2024.21-05-2024
GPT Healthcare Ltd - 544131 - Corporate Action- Book Closure For Dividend And AGM
Please find the details of Book Closure for Dividend and AGM.21-05-2024
GPT Healthcare Ltd - 544131 - Corporate Action-Record Date For Dividend
Please find the record date for final dividend.21-05-2024